Atherogenic lipoprotein phenotype in type 2 diabetes: reversal with micronised fenofibrate. - Feher,MD.; Caslake,M.; Foxton,J.; Cox,A.; Packard,CJ. (Diabetes Metab Res Rev, 1999)